PYC pyc therapeutics limited

I sort of agree. It is not an obvious transition but most Aussie...

  1. ds
    7,131 Posts.
    I sort of agree.

    It is not an obvious transition but most Aussie Bios are too small to carry a commercial only CEO - it's like a school thinking it can run with the Principal being a business manager only.

    I think RH made a great transition and even the 2nd half of last year did a good job of investor relations but to a very limited audience. Unfortunately we are getting to 3-6 months past that run but as we have been saying hopefully they are just cranking out the science making great headway - it is just starting to feel like the other parts of the role are being forgotten - maybe it all gets fixed in the next month or 2 cause they have been so focused internally. The risk I am trying to identify is that they avoid the accusation of only bothering with shareholders when they need money - I think I have been very patient with this but it does require constant managing.

    There will be no takeout at anything like a normal premium - when you have a major shareholder with a stake like the Hockings they set the staring price if there ever was a buyer and my thinking is they think in the hundreds of millions within 3 years. Like you say - gotta get the MCAP closer to that first.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.27
Change
0.005(0.40%)
Mkt cap ! $740.7M
Open High Low Value Volume
$1.27 $1.29 $1.27 $406.0K 319.3K

Buyers (Bids)

No. Vol. Price($)
1 13987 $1.27
 

Sellers (Offers)

Price($) Vol. No.
$1.29 1380 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.